Cellebrite DI (CLBT) Current Assets (2020 - 2025)

Cellebrite DI's Current Assets history runs 6 years deep, the most recent figure standing at $575.8 million for Q4 2025.

• On a quarterly basis, Current Assets rose 1.45% year-over-year to $575.8 million in Q4 2025; TTM through Dec 2025 was $575.8 million, a 1.45% increase from a year earlier, with the FY2025 full-year figure at $575.8 million, up 1.45% from the prior year.
• Current Assets retreated to $575.8 million in Q4 2025 per CLBT's latest filing, from $668.4 million in the prior quarter.
• Across five years, Current Assets topped out at $668.4 million in Q3 2025 and bottomed at $233.6 million in Q2 2022.
• The 5-year median for Current Assets is $376.2 million (2023), against an average of $403.7 million.
• Across the five-year window, Current Assets declined 15.75% in 2021 and jumped 46.14% in 2025, its largest moves.
• Year by year, Current Assets stood at $273.2 million in 2021, then gained by 8.32% to $295.9 million in 2022, then soared by 42.63% to $422.1 million in 2023, then soared by 34.47% to $567.6 million in 2024, then increased by 1.45% to $575.8 million in 2025.
• Per Business Quant, the three latest CLBT Current Assets figures stand at $575.8 million (Q4 2025), $668.4 million (Q3 2025), and $606.1 million (Q2 2025).